LILRB2 and systemic lupus erythematosus: Consistently, when we evaluated the surface expression of ILT4 (measured as the mean fluorescence intensity, MFI) in mDC and pDC, we observed that SLE patients DC displayed a lower expression of this receptor (Figure 1(d)).